Cigna Corp (CI)

Currency in USD
282.90
-7.68(-2.64%)
Closed·
283.31+0.41(+0.14%)
·
CI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
281.31290.14
52 wk Range
239.51338.89
Key Statistics
Prev. Close
290.58
Open
289.08
Day's Range
281.31-290.14
52 wk Range
239.51-338.89
Volume
1.52M
Average Vol. (3m)
1.74M
1-Year Change
-15.0129%
Book Value / Share
160.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
338.29
Upside
+19.58%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Cigna Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

22 Buy
2 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 338.29
(+19.58% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy337.00+19.12%306.00MaintainMay 01, 2026
Wells Fargo
Hold305.00+7.81%300.00MaintainMay 01, 2026
Cantor Fitzgerald
Buy340.00+20.18%325.00MaintainMay 01, 2026
RBC Capital
Buy337.00+19.12%333.00MaintainMay 01, 2026
Mizuho
Buy330.00+16.65%325.00MaintainMay 01, 2026

Cigna Corp SWOT Analysis


Market Positioning
Delve into Cigna's strategic gains in the $300 billion Select employer segment and its specialty pharmacy innovations, balanced against regulatory uncertainties and competitive pressures.
Analyst Confidence
Explore the bullish outlook from major firms, with price targets averaging $358—ranging from $300 to $383—and predominantly "Overweight" ratings signaling strong growth potential.
Financial Resilience
With EPS estimates of $29.60 for FY1 and ranging between $30.70-$33.75 for FY2, Cigna maintains a robust 10-14% long-term growth trajectory supported by a $7.7 billion buyback program.
PBM Innovation
Cigna's new Pharmacy Benefit Management model strategically positions the company to mitigate regulatory risks while creating competitive differentiation in the healthcare market.
Read full SWOT analysis

Cigna Corp Earnings Call Summary for Q1/2026

  • Cigna Q1 2026 EPS of $7.79 beat estimates by 2.37%; revenue hit $68.52B, up 3.5% vs. forecast, with 16% YoY EPS growth.
  • Stock fell 0.97% pre-market to $289.47 despite strong results; trades at P/E of 12.74 with PEG ratio of 0.16, suggesting undervaluation.
  • Raised full-year 2026 EPS guidance to at least $30.35; Q2 EPS expected at ~25% of annual outlook with focus on debt reduction and buybacks.
  • CEO Cordani cited disciplined execution and momentum across segments; strategic investments in Pharmacy Benefit Services may pressure near-term earnings.
  • Company transitions to rebate-free model and exits individual exchange business; maintains aggressive share repurchases and 5-year dividend growth streak.
Last Updated: 04/30/2026, 10:16 AM
Read Full Transcript

Earnings

Latest Release
Apr 30, 2026
EPS / Forecast
7.79 / 7.61
Revenue / Forecast
68.52B / 66.2B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 23.87%
Dividend Yield
2.13%
Industry Median 2.29%
Annualized Payout
6.24
Paid quarterly
5-Years Growth
+172.77%
Growth Streak

CI Income Statement

Compare CI to Peers and Sector

Metrics to compare
CI
Peers
Sector
Relationship
P/E Ratio
11.9x12.2x−0.5x
PEG Ratio
0.360.550.00
Price / Book
1.8x2.7x2.6x
Price / LTM Sales
0.3x1.4x3.2x
Upside (Analyst Target)
19.3%31.9%47.8%
Fair Value Upside
Unlock6.4%6.7%Unlock

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
126.40M47.94%36.73B
Other Institutional Investors
116.42M44.15%33.83B
Public Companies & Retail Investors
20.84M7.90%6.06B
Total
263.66M100.00%76.61B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Vanguard Group, Inc.10.03%26,445,6897,684,588
BlackRock, Inc.8.78%23,155,5116,728,528

People Also Watch

112.33
EPAM
-1.27%
250.71
ADBE
+1.87%
62.14
FISV
-0.81%
399.04
INTU
+2.71%
1,187.00
SNDK
+8.25%

FAQ

What Is the Cigna (CI) Stock Price Today?

The Cigna stock price today is 282.90 USD.

What Stock Exchange Does Cigna Trade On?

Cigna is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Cigna?

The stock symbol for Cigna is "CI."

Does Cigna Pay Dividends? What’s The Current Dividend Yield?

The Cigna dividend yield is 2.21%.

What Is the Cigna Market Cap?

As of today, Cigna market cap is 74.84B USD.

What Is Cigna's Earnings Per Share (TTM)?

The Cigna EPS (TTM) is 23.87.

When Is the Next Cigna Earnings Date?

Cigna will release its next earnings report on Jul 30, 2026.

From a Technical Analysis Perspective, Is CI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cigna Stock Split?

Cigna has split 2 times.

How Many Employees Does Cigna Have?

Cigna has 66685 employees.

What is the current trading status of Cigna (CI)?

As of May 02, 2026, Cigna (CI) is trading at a price of 282.90 USD, with a previous close of 290.58 USD. The stock has fluctuated within a day range of 281.31 USD to 290.14 USD, while its 52-week range spans from 239.51 USD to 338.89 USD.

What Is Cigna (CI) Price Target According to Analysts?

The average 12-month price target for Cigna is 338.29 USD, with a high estimate of 378 USD and a low estimate of 290 USD. 22 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +19.58% Upside potential.

What Is the CI Premarket Price?

CI's last pre-market stock price is 274.25 USD. The pre-market share volume is 80.00, and the stock has decreased by -16.33, or -5.62%.

What Is the CI After Hours Price?

CI's last after hours stock price is 283.31 USD, the stock has decreased by 0.41, or 0.14%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.